Medications for Chronic Lymphocytic Leukemia Bcell
13 results
Bendamustine hydrochloride (bendamustine hydrochloride)
(bendamustine hydrochloride)Baxter Healthcare Corporation
Usage: Bendamustine Hydrochloride Injection is indicated for treating adult patients with chronic lymphocytic leukemia (CLL) and for indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of rituximab therapy. Efficacy against other first-line treatments has not been established.
Brukinsa (zanubrutinib)
(zanubrutinib)BEIGENE USA, INC.
Usage: BRUKINSA is indicated for the treatment of adult patients with mantle cell lymphoma, Waldenström's macroglobulinemia, relapsed or refractory marginal zone lymphoma, chronic lymphocytic leukemia or small lymphocytic lymphoma, and relapsed or refractory follicular lymphoma in combination with obinutuzumab, following prior therapies.
Calquence (acalabrutinib)
(Acalabrutinib)AstraZeneca Pharmaceuticals LP
Usage: CALQUENCE is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) after prior therapy, and for those with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Approval for MCL is based on an accelerated approval process contingent on further clinical benefit verification.
Conray (iothalamate meglumine)
(iothalamate meglumine)Liebel-Flarsheim Company LLC
Usage: Conray is indicated for excretory urography, angiography (cerebral, peripheral, venous), and various imaging techniques like computed tomography (CT) for detecting lesions in organs such as the liver and kidneys. It enhances diagnostic accuracy and visualization of lesions compared to unenhanced CT scans.
Cyclophosphamide (cyclophosphamide for injection)
(Cyclophosphamide for Injection)Slate Run Pharmaceuticals, LLC
Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Dr. Reddy's Laboratories Inc.
Usage: Cyclophosphamide is indicated for treating malignant diseases in adults and pediatric patients, including various lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is often used in combination with other antineoplastic agents.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Civica, Inc.
Usage: Cyclophosphamide for Injection is indicated for treating various malignant diseases in adults and children, including malignant lymphomas, multiple myeloma, leukemias, and neuroblastoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to or cannot tolerate corticosteroids.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Bamboo US BidCo LLC
Usage: Cyclophosphamide is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, and certain solid tumors. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who have not responded to corticosteroid therapy. Safety in adults for nephrotic syndrome is unestablished.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)Bamboo US BidCo LLC
Usage: Cyclophosphamide is indicated for treating various malignant diseases including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy is ineffective or intolerable.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)NextSource Pharma
Usage: Cyclophosphamide Capsules are indicated for treating various malignant diseases, including malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids.